Wednesday October 21, 2020

Inflazome success story is an inspiration to Irish business

Comment: The acquisition of the campus company by Swiss giant Roche shows that Irish science can work productively with entrepreneurs and venture capitalists

27th September, 2020
The €380 million sale of Inflazome, which originated from research carried out by Professor Luke O’Neill, shows Ireland can compete with the best in the world when academia and business collaborate. Picture: Fergal Phillips

Last week‘s acquisition of the campus company Inflazome by Roche, the Swiss pharmaceutical giant, is one of the biggest deals in recent Irish corporate history. The €380 million sale of this small Irish biotech firm, which originated from research carried out by Professor Luke O’Neill of Trinity College Dublin, demonstrates that Ireland can compete with the best in the world when academia and business collaborate.

Deals of this scale are an...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

This product does not auto-renew

Team Pass

Get a Business Account for you and your team

Related Stories

Despite the record €4 billion boost for health services last week, there was little detail on how reform as laid out in the ten-year plan would be implemented

Róisín Shortall | 19 hours ago

Budget should have recognised those who risked their lives to save others during the first wave of Covid-19 — and who now face a most stressful and hazardous winter

Susan O'Keeffe | 1 day ago

The new proposals would be a radical change from current rules, at a time when our exchequer needs every euro it can get

Ian Guider | 1 day ago